Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Suspect Hepatitis C (HCV) Clinical Research Samples
Discovery Life Sciences provides the highest quality Suspect Hepatitis C (HCV) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Suspect Hepatitis C (HCV) Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Advanced Data View:
Showing 501 of 501 total samples
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Detail 1 | Test 2 | Test Data 2 | Detail 2 | Test 3 | Test Data 3 | Product Details | Price | Buy | Western Blot | Abbott Architect | Risk Categories | Vaccinated for Hepatitis A | Vaccinated for Hepatitis B | Vaccinated for Influenza within 60 days prior to phlebotomy | Subject Taking Vitamin B7 (Biotin) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DSP3800-BU900052406022812DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 7.00 | $125.00 | 45 Y | F | Black | <-70C | 28-Feb-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900052406022812DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 45 Y | F | Black | <-70C | 28-Feb-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900052417061312DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 26 Y | F | Black | <-70C | 14-Jun-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900052417061312DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 3.00 | $125.00 | 26 Y | F | Black | <-70C | 14-Jun-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900057146031812DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 38 Y | F | Black | <-70C | 19-Mar-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900057146031812DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 3.00 | $125.00 | 38 Y | F | Black | <-70C | 19-Mar-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900057147031912DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 22 Y | M | Black | <-70C | 20-Mar-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900057147031912DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 22 Y | M | Black | <-70C | 20-Mar-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-AC900057148051212DD | Suspect Hepatitis C (HCV) | Mexico | Plasma | 1.00 | 5.00 | $125.00 | 24 Y | M | U/A | <-70C | 13-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-AC900057148051212DD | Suspect Hepatitis C (HCV) | Mexico | Serum | 1.00 | 4.00 | $125.00 | 24 Y | M | U/A | <-70C | 13-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-AC900057149040912DD | Suspect Hepatitis C (HCV) | Mexico | Plasma | 1.00 | 5.00 | $125.00 | 29 Y | F | U/A | <-70C | 10-Apr-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| BBS0005-AC900057149040912DD | Suspect Hepatitis C (HCV) | Mexico | Serum | 1.00 | 1.00 | $125.00 | 29 Y | F | U/A | <-70C | 10-Apr-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-CD900064062011513DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 3.00 | $125.00 | 20 Y | F | White | <-70C | 15-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-CD900064062011513DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 20 Y | F | White | <-70C | 15-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900064064041112DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 8.00 | $125.00 | 38 Y | M | Black | <-70C | 12-Apr-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| BBS0005-BU900064064041112DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 38 Y | M | Black | <-70C | 12-Apr-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-AC900064076091412DD | Suspect Hepatitis C (HCV) | Mexico | Plasma | 1.00 | 8.00 | $125.00 | 49 Y | F | U/A | <-70C | 15-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| BBS0005-AC900064076091412DD | Suspect Hepatitis C (HCV) | Mexico | Serum | 1.00 | 2.00 | $125.00 | 49 Y | F | U/A | <-70C | 15-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-AC900064077051813DD | Suspect Hepatitis C (HCV) | Mexico | Plasma | 1.00 | 4.00 | $125.00 | 20 Y | F | U/A | <-70C | 19-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-AC900069458092412DD | Suspect Hepatitis C (HCV) | Mexico | Plasma | 1.00 | 7.00 | $125.00 | 38 Y | M | U/A | <-70C | 25-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-CC900069459051712DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 7.00 | $125.00 | 56 Y | F | Black | <-70C | 18-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-CC900069459051712DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 5.00 | $125.00 | 56 Y | F | Black | <-70C | 18-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-CC900069460052812DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 7.00 | $125.00 | 33 Y | F | Black | <-70C | 29-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| BBS0005-CC900069460052812DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 33 Y | F | Black | <-70C | 29-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-AC900069462100412DD | Suspect Hepatitis C (HCV) | Mexico | Plasma | 1.00 | 4.00 | $125.00 | 19 Y | M | U/A | <-70C | 05-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-AC900069462100412DD | Suspect Hepatitis C (HCV) | Mexico | Serum | 1.00 | 2.00 | $125.00 | 19 Y | M | U/A | <-70C | 05-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-AC900074789081812DD | Suspect Hepatitis C (HCV) | Mexico | Plasma | 1.00 | 8.00 | $125.00 | 29 Y | F | U/A | <-70C | 19-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-AC900074789081812DD | Suspect Hepatitis C (HCV) | Mexico | Serum | 1.00 | 4.00 | $125.00 | 29 Y | F | U/A | <-70C | 19-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900074796090912DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 7.00 | $125.00 | 58 Y | F | Black | <-70C | 10-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900074796090912DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 4.00 | $125.00 | 58 Y | F | Black | <-70C | 10-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900074797091312DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 8.00 | $125.00 | 46 Y | F | White | <-70C | 14-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900074797091312DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 6.00 | $125.00 | 46 Y | F | White | <-70C | 14-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900074799090512DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 23 Y | M | Black | <-70C | 06-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900079066090412DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 9.00 | $125.00 | 50 Y | F | Black | <-70C | 05-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900079066090412DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 6.00 | $125.00 | 50 Y | F | Black | <-70C | 05-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900079077100712DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 4.00 | $125.00 | 36 Y | F | Hispanic | <-70C | 08-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900079077100712DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $125.00 | 36 Y | F | Hispanic | <-70C | 08-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900079079102112DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 8.00 | $125.00 | 28 Y | F | Black | <-70C | 22-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900079079102112DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 4.00 | $125.00 | 28 Y | F | Black | <-70C | 22-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900079080091612DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 6.00 | $125.00 | 31 Y | M | Black | <-70C | 17-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900079080091612DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $125.00 | 31 Y | M | Black | <-70C | 17-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900032895101712DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 9.00 | $125.00 | 39 Y | M | Hispanic | <-70C | 18-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900032895101712DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 6.00 | $125.00 | 39 Y | M | Hispanic | <-70C | 18-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900032896080112DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 23 Y | M | Black | <-70C | 02-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| BBS0005-BU900032896080112DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 23 Y | M | Black | <-70C | 02-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-CC900032897080612DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 8.00 | $125.00 | 51 Y | F | Black | <-70C | 07-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-CC900032897080612DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 5.00 | $125.00 | 51 Y | F | Black | <-70C | 07-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-MB900032899090912DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 9.00 | $125.00 | 51 Y | F | U/A | <-70C | 10-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-MB900032899090912DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 5.00 | $125.00 | 51 Y | F | U/A | <-70C | 10-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900032903010713DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 27 Y | F | Black | <-70C | 07-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.1 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900032903010713DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 27 Y | F | Black | <-70C | 07-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900032906020413DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 3.00 | $125.00 | 36 Y | M | White | <-70C | 04-Feb-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900032906020413DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $125.00 | 36 Y | M | White | <-70C | 04-Feb-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900032907021413DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 4.00 | $125.00 | 59 Y | M | American Indian | <-70C | 14-Feb-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900032907021413DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 59 Y | M | American Indian | <-70C | 14-Feb-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900036888031113DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 8.00 | $125.00 | 50 Y | F | Black | <-70C | 12-Mar-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| BBS0005-BU900036888031113DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $125.00 | 50 Y | F | Black | <-70C | 12-Mar-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-BU900036889111512DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 9.00 | $125.00 | 54 Y | F | Black | <-70C | 15-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900036889111512DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 6.00 | $125.00 | 54 Y | F | Black | <-70C | 15-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900036890102412DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 6.00 | $125.00 | 23 Y | F | Black | <-70C | 25-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900036891112312DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 8.00 | $125.00 | 54 Y | M | Black | <-70C | 23-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900036891112312DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $125.00 | 54 Y | M | Black | <-70C | 23-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900036900110512DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 8.00 | $125.00 | 43 Y | M | Black | <-70C | 05-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900036900110512DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 5.00 | $125.00 | 43 Y | M | Black | <-70C | 05-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900042698120512DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 21 Y | M | White | <-70C | 05-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900042698120512DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 21 Y | M | White | <-70C | 05-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900042703120712DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 6.00 | $125.00 | 55 Y | F | Black | <-70C | 07-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900042703120712DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 3.00 | $125.00 | 55 Y | F | Black | <-70C | 07-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900050689122712DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 6.00 | $125.00 | 34 Y | F | Black | <-70C | 27-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| BBS0005-BU900050689122712DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 3.00 | $125.00 | 34 Y | F | Black | <-70C | 27-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-BU900050690111612DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 7.00 | $125.00 | 56 Y | F | Black | <-70C | 16-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900050690111612DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $125.00 | 56 Y | F | Black | <-70C | 16-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900050691012813DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 26 Y | F | Black | <-70C | 28-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| BBS0005-BU900050691012813DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 26 Y | F | Black | <-70C | 28-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-BU900054744110612DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 8.00 | $125.00 | 57 Y | M | Black | <-70C | 06-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-MB900054745112012DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 8.00 | $125.00 | 22 Y | F | Black | <-70C | 20-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-MB900054745112012DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 22 Y | F | Black | <-70C | 20-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-DI900054746071413DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 54 Y | F | Black | <-70C | 15-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-DI900054746071413DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 3.00 | $125.00 | 54 Y | F | Black | <-70C | 15-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-DI900054754071413DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 57 Y | M | White | <-70C | 15-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-DI900054754071413DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 4.00 | $125.00 | 57 Y | M | White | <-70C | 15-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-DI900061420071813DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 4.00 | $125.00 | 27 Y | M | Black | <-70C | 19-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-DI900061420071813DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 3.00 | $125.00 | 27 Y | M | Black | <-70C | 19-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-DI900061421072513DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 6.00 | $125.00 | 54 Y | M | Black | <-70C | 26-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-DI900061421072513DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 54 Y | M | Black | <-70C | 26-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-DI900061422072913DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 4.00 | $125.00 | 74 Y | F | White | <-70C | 30-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-DI900061422072913DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $125.00 | 74 Y | F | White | <-70C | 30-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-DI900061431073013DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 4.00 | $125.00 | 38 Y | F | White | <-70C | 31-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-DI900061431073013DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 38 Y | F | White | <-70C | 31-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-DI900066901073013DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 53 Y | F | Filipino | <-70C | 31-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-DI900066901073013DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $125.00 | 53 Y | F | Filipino | <-70C | 31-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-DI900066904080713DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 6.00 | $125.00 | 58 Y | M | Black | <-70C | 08-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-DI900066904080713DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 58 Y | M | Black | <-70C | 08-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-DI900066905080813DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 7.00 | $125.00 | 77 Y | F | Black | <-70C | 09-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-DI900066905080813DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $125.00 | 77 Y | F | Black | <-70C | 09-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-DI900066906080813DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 4.00 | $125.00 | 56 Y | M | Black | <-70C | 09-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-DI900066906080813DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 3.00 | $125.00 | 56 Y | M | Black | <-70C | 09-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-DI900036168112613DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 4.00 | $125.00 | 52 Y | F | White | <-70C | 26-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-DI900036168112613DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $125.00 | 52 Y | F | White | <-70C | 26-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-DI900036169112013DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 3.00 | $125.00 | 58 Y | M | White | <-70C | 20-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-DI900036169112013DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $125.00 | 58 Y | M | White | <-70C | 20-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-DI900036170111313DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 62 Y | F | White | <-70C | 13-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-DI900036170111313DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 3.00 | $125.00 | 62 Y | F | White | <-70C | 13-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-DI900036177111913DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 34 Y | F | White | <-70C | 19-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-DI900036177111913DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 34 Y | F | White | <-70C | 19-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900057174042913DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 4.00 | $125.00 | 42 Y | F | White | <-70C | 30-Apr-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900057174042913DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $125.00 | 42 Y | F | White | <-70C | 30-Apr-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900057176060913DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 8.00 | $125.00 | 32 Y | M | Black | <-70C | 10-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900057176060913DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 3.00 | $125.00 | 32 Y | M | Black | <-70C | 10-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900057177041613DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 7.00 | $125.00 | 25 Y | M | Black | <-70C | 17-Apr-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900057177041613DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 25 Y | M | Black | <-70C | 17-Apr-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBP0000-BU900106672060513DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 4.00 | $125.00 | 34 Y | F | Black | <-70C | 06-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | N/A | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 57 U/L | 31 U/L | 27 U/L ALP | AST | ALT 7.4 g/dL | 4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing, piercing) | |||||||||
| BBS0000-BU900106672060513DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 34 Y | F | Black | <-70C | 06-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | N/A | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 57 U/L | 31 U/L | 27 U/L ALP | AST | ALT 7.4 g/dL | 4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing, piercing) | |||||||||
| DSP3800-AC900065316032513DD | Suspect Hepatitis C (HCV) | Mexico | Plasma | 1.00 | 6.00 | $75.00 | 50 Y | M | U/A | <-70C | 26-Mar-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $75.00 | ||||||||||||
| DSP3800-AC900065317050513DD | Suspect Hepatitis C (HCV) | Mexico | Plasma | 1.00 | 6.00 | $125.00 | 35 Y | F | U/A | <-70C | 06-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| BBS0005-AC900065317050513DD | Suspect Hepatitis C (HCV) | Mexico | Serum | 1.00 | 2.00 | $125.00 | 35 Y | F | U/A | <-70C | 06-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-AC900065318032813DD | Suspect Hepatitis C (HCV) | Mexico | Plasma | 1.00 | 5.00 | $125.00 | 22 Y | M | U/A | <-70C | 29-Mar-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-AC900065318032813DD | Suspect Hepatitis C (HCV) | Mexico | Serum | 1.00 | 5.00 | $125.00 | 22 Y | M | U/A | <-70C | 29-Mar-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BV900065319042913DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 3.00 | $125.00 | 29 Y | M | Black | <-70C | 30-Apr-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-BV900069484050713DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 2.00 | $125.00 | 43 Y | M | White | <-70C | 08-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-BV900069485050813DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 40 Y | M | Indian | <-70C | 09-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-BV900069486052013DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 4.00 | $125.00 | 41 Y | M | White | <-70C | 21-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| BBS0005-BV900069486052013DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 41 Y | M | White | <-70C | 21-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-MB900069490061813DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 6.00 | $125.00 | 40 Y | F | White | <-70C | 19-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-MB900069490061813DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $125.00 | 40 Y | F | White | <-70C | 19-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-MB900066336052813DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 4.00 | $125.00 | 37 Y | M | White | <-70C | 29-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| BBS0005-MB900066336052813DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $125.00 | 37 Y | M | White | <-70C | 29-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-BV900066337062413DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 4.00 | $125.00 | 35 Y | M | Asian | <-70C | 25-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-BV900066338082913DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 29 Y | M | Black | <-70C | 30-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| BBS0005-BV900066338082913DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $125.00 | 29 Y | M | Black | <-70C | 30-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-BU900066340112513DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 3.00 | $125.00 | 50 Y | F | Black | <-70C | 25-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900066340112513DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $125.00 | 50 Y | F | Black | <-70C | 25-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900036004013014DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 60 Y | F | Black | <-70C | 30-Jan-14 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900036004013014DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 3.00 | $125.00 | 60 Y | F | Black | <-70C | 30-Jan-14 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900036005092413DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 38 Y | M | White | <-70C | 25-Sep-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900036005092413DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 38 Y | M | White | <-70C | 25-Sep-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900036006111313DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 5.00 | $125.00 | 52 Y | M | Black | <-70C | 13-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-BU900036007121113DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 9.00 | $125.00 | 37 Y | F | Black | <-70C | 11-Dec-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-BU900036007121113DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $125.00 | 37 Y | F | Black | <-70C | 11-Dec-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-BU900036008122313DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 3.00 | $125.00 | 30 Y | M | Black | <-70C | 23-Dec-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-FC900041696102313DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 4.00 | $125.00 | 49 Y | M | Black | <-70C | 24-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-FC900041697102313DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 3.00 | $125.00 | 28 Y | M | Black | <-70C | 24-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| BBS0005-FC900041697102313DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $125.00 | 28 Y | M | Black | <-70C | 24-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-FC900041698102813DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 4.00 | $125.00 | 41 Y | F | Black | <-70C | 29-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| BBS0005-FC900041698102813DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 41 Y | F | Black | <-70C | 29-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $125.00 | ||||||||||||
| DSP3800-FC900041699102813DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 4.00 | $125.00 | 52 Y | M | Black | <-70C | 29-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| BBS0005-FC900041699102813DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $125.00 | 52 Y | M | Black | <-70C | 29-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| DSP3800-FC900041700102813DD | Suspect Hepatitis C (HCV) | USA | Plasma | 1.00 | 4.00 | $125.00 | 54 Y | M | Black | <-70C | 29-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $125.00 | ||||||||||||
| BBS0005-BD900023627092419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 25 Y | M | Black | <-70C | 25-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-BD900026637091919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 30 Y | M | White | <-70C | 20-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-BD900026638090919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 27 Y | M | Black | <-70C | 10-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-BD900026639090819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 17.00 | $150.00 | 44 Y | M | White | <-70C | 09-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-BD900026640091519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 45 Y | F | Black | <-70C | 16-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-BD900026641091119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 21 Y | M | Black | <-70C | 12-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-BD900026642090219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 17.00 | $150.00 | 27 Y | M | Black | <-70C | 03-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-BD900027871082519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 17.00 | $150.00 | 29 Y | M | Black | <-70C | 26-Aug-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-BD900027872080419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 59 Y | M | White | <-70C | 05-Aug-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-BD900027873082519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 57 Y | M | White | <-70C | 26-Aug-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-BD900027874080519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 17.00 | $150.00 | 54 Y | F | Black | <-70C | 06-Aug-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-BD900027875072819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 17.00 | $150.00 | 49 Y | M | Black | <-70C | 29-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-BD900027876080419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 18.00 | $150.00 | 40 Y | F | Black | <-70C | 05-Aug-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-BD900027877071819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 35 Y | M | Black | <-70C | 19-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-BD900027878063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 33 Y | M | Black | <-70C | 01-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-BD900027879072119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 54 Y | F | Black | <-70C | 22-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-BD900027880070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 18.00 | $150.00 | 46 Y | M | Black | <-70C | 02-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-BD900111817070419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 58 Y | F | Black | <-70C | 05-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | ||||||||||
| BBS0005-CC900024277051219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 34 Y | F | Black | <-70C | 13-May-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 1st | $150.00 | |||||||||||
| BBS0005-CC900024278051219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 33 Y | F | Black | <-70C | 13-May-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 1st | $150.00 | |||||||||||
| BBS0005-CC900024279063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 29 Y | F | White | <-70C | 01-Jul-19 | Subject Risk Information | HIV infected individuals | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-CC900024282062419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 26 Y | F | Black | <-70C | 25-Jun-19 | Subject Risk Information | HIV infected individuals | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-CC900024283042919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 6.00 | $200.00 | 25 Y | F | Black | <-70C | 30-Apr-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $200.00 | |||||||||||
| BBS0005-CC900024284050119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 5.00 | $150.00 | 34 Y | F | Black | <-70C | 02-May-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 2nd | $150.00 | |||||||||||
| BBS0005-CC900024285041019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $200.00 | 27 Y | F | Black | <-70C | 11-Apr-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 2nd | $200.00 | |||||||||||
| BBS0005-CC900024286042419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $200.00 | 25 Y | F | Black | <-70C | 25-Apr-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $200.00 | |||||||||||
| BBS0005-CC900024287042419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 4.00 | $200.00 | 26 Y | F | White | <-70C | 25-Apr-19 | Subject Risk Information | Current or former user of IV drugs | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $200.00 | |||||||||||
| BBS0005-CC900024288041019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $200.00 | 33 Y | F | White | <-70C | 11-Apr-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 2nd | $200.00 | |||||||||||
| BBS0005-CC900028029022619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 3.00 | $200.00 | 32 Y | F | Black | <-70C | 26-Feb-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 1st | $200.00 | |||||||||||
| BBS0005-CC900028030042219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $200.00 | 19 Y | F | White | <-70C | 23-Apr-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 2nd | $200.00 | |||||||||||
| BBS0005-CC900028031042219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $200.00 | 27 Y | F | Black | <-70C | 23-Apr-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $200.00 | |||||||||||
| BBS0005-CC900028032060519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 5.00 | $150.00 | 28 Y | F | Black | <-70C | 06-Jun-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 2nd | $150.00 | |||||||||||
| BBS0005-CC900028033052719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 30 Y | F | Black | <-70C | 28-May-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $150.00 | |||||||||||
| BBS0005-CC900028034060519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 21 Y | F | White | <-70C | 06-Jun-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $150.00 | |||||||||||
| BBS0005-CC900028042051919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 35 Y | F | Black | <-70C | 20-May-19 | Subject Risk Information | HIV infected individuals, Previous laparoscopic sleeve gastrectomy in the past | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $150.00 | |||||||||||
| BBS0005-CC900028043051919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 33 Y | F | Black | <-70C | 20-May-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 1st | $150.00 | |||||||||||
| BBS0000-A0900109887062319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 17.00 | $150.00 | 66 Y | F | Black | <-70C | 24-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900110004072219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 65 Y | F | White | <-70C | 23-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900110005081219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 68 Y | F | Black | <-70C | 13-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Ascites | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900110006082019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 57 Y | M | White | <-70C | 21-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Ascites | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900110007062319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 69 Y | M | White | <-70C | 24-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900111845070919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 69 Y | F | White | <-70C | 10-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900111846081919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 64 Y | M | White | <-70C | 20-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Yes 4-Apr-18 | No | No | No | ||||||||||
| BBS0005-CC900022537060919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 6.00 | $150.00 | 54 Y | M | White | <-70C | 10-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 48 U/L: Test Date 10-Jun-2019 | $150.00 | ||||||||||||
| BBS0005-CF900022538062419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 62 Y | F | White | <-70C | 25-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 307 U/L; ALT: 132 U/L | 25-Jun-19 | $150.00 | ||||||||||||
| BBS0000-CC900107988061219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 5.00 | $150.00 | 52 Y | F | Black | <-70C | 13-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 82 U/L; ALT: 69 U/L: Test Date 13-Jun-2019 | $150.00 | No | No | ||||||||||
| BBS0000-CF900107989063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 18.00 | $150.00 | 55 Y | F | White | <-70C | 01-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Ascites; Enlarged liver | $150.00 | Yes Date of Vaccination: U/A | Yes Date of Vaccination: U/A | No | No | |||||||||
| BBS0000-CF900107990052819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 53 Y | F | U/A | <-70C | 29-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 43 U/L; ALT: 47 U/L: Test Date 29-May-2019 | $150.00 | No | No | ||||||||||
| BBS0000-CC900111838060319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 5.00 | $150.00 | 32 Y | M | Hispanic | <-70C | 04-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | No | No | |||||||||||
| BBS0000-CF900111839062519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 48 Y | M | White | <-70C | 26-Jun-19 | Subject Risk Information | Blood, blood component or organ recipient prior to 1992 (1987) | Suspect HCV:Adult | Primary Signs and Symptoms | Enlarged liver | $150.00 | U/A | U/A | No | Yes | |||||||||
| BBS0000-CF900111828052919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 46 Y | F | White | <-70C | 30-May-19 | Subject Risk Information | Long term hemodialysis patients; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 177 U/L; AST: 74 U/L; ALT: 126 U/L:Test Date 30-May-2019 | $150.00 | No | No | ||||||||||
| BBS0005-CC900024128061119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 59 Y | M | White | <-70C | 12-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 49 U/L; ALP: 364 U/L Test Date: 11-Jun-2019 | $150.00 | ||||||||||||
| BBS0005-CF900024129060219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 57 Y | F | White | <-70C | 03-Jun-19 | Subject Risk Information | Long term hemodialysis patients; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 218 U/L: Test Date 3-Jun-2019 | $150.00 | ||||||||||||
| BBS0005-CF900027862062619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 73 Y | F | Asian | <-70C | 27-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 39 U/L; ALP: 60 U/L | 27-Jun-19 | $150.00 | ||||||||||||
| BBS0005-CC900027863061219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $200.00 | 64 Y | M | Hispanic | <-70C | 13-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 160 U/L: Test Date 13-Jun-2019 | $200.00 | ||||||||||||
| BBS0005-CF900027864070219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $150.00 | 75 Y | M | White | <-70C | 03-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 46 U/L | 02-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CC900027865061219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 19 Y | M | Hispanic | <-70C | 13-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Pediatric | Primary Signs and Symptoms | Elevated liver enzymes | AST: 85 U/L: Test Date 13-Jun-2019 | $150.00 | ||||||||||||
| BBS0005-CC900027866061019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 4.00 | $150.00 | 62 Y | F | White | <-70C | 11-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | |||||||||||||
| BBS0005-CF900027867052919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 35 Y | M | Hispanic | <-70C | 30-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 56 U/L; ALT: 52 U/L: Test Date 30-May-2019 | $150.00 | ||||||||||||
| BBS0005-CF900027868060219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 51 Y | M | Hispanic | <-70C | 03-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | ALT: 59 U/L: Test Date 3-Jun-2019 | $150.00 | ||||||||||||
| BBS0005-CF900027869062519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 69 Y | M | Hispanic | <-70C | 26-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice; Elevated liver enzymes | AST: 64 U/L; ALT: 79 U/L; ALP: 634 U/L | 26-Jun-19 | $150.00 | ||||||||||||
| BBS0005-CF900027870062419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 66 Y | F | White | <-70C | 25-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 171 U/L | 24-Jun-19 | $150.00 | ||||||||||||
| BBS0005-CF900031091072919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 77 Y | M | Hispanic | <-70C | 30-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 558 U/L; ALT: 355 U/L; ALP: 177 U/L | 29-Jul-2019 | $150.00 | ||||||||||||
| BBS0005-CF900031092071719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 70 Y | M | White | <-70C | 18-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 56 U/L | 18-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CC900031093061119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 57 Y | M | Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | |||||||||||||
| BBS0005-CF900031094072319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 37 Y | F | Black | <-70C | 24-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 151 U/L | 24-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900031095070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 0.60 | 1.00 | $150.00 | 22 Y | F | Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 133 U/L | 01-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CC900031096060419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 6.00 | $150.00 | 54 Y | M | Hispanic | <-70C | 05-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 55 U/L; ALT: 65 U/L: Test Date 5-Jun-2019 | $150.00 | ||||||||||||
| BBS0005-CF900031097062519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 83 Y | F | Black | <-70C | 26-Jun-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 46 U/L; ALT: 58 U/L | 26-Jun-19 | $150.00 | ||||||||||||
| BBS0005-CF900031098071619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 31 Y | F | White | <-70C | 17-Jul-19 | Subject Risk Information | Blood, blood component or organ recipient prior to 1992 | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice; Elevated liver enzymes | AST: 287 U/L; ALT: 69 U/L; ALP: 455 U/L | 17-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900037603052719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 58 Y | F | Black | <-70C | 28-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | |||||||||||||
| BBS0005-CF900037604063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 48 Y | F | Black | <-70C | 01-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 59 U/L | 30-Jun-19 | $150.00 | ||||||||||||
| BBS0005-CC900037605061119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 62 Y | F | Hawaiian | <-70C | 12-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Ascites; Elevated liver enzymes | AST: 97 U/L; ALT: 65 U/L:Test Date 12-Jun-2019 | $150.00 | ||||||||||||
| BBS0005-CC900037606061119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 25 Y | F | Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | Long term hemodialysis patients | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | |||||||||||||
| BBS0005-CC900037607060919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $150.00 | 54 Y | M | American Indian | <-70C | 10-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 102 U/L; ALP: 1697 U/L: Test Date 10-Jun-2019 | $150.00 | ||||||||||||
| BBS0005-CF900037608052819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 59 Y | F | Asian | <-70C | 29-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | |||||||||||||
| BBS0005-CF900037609052819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 61 Y | F | White | <-70C | 29-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice, Elevated liver enzymes | AST: 94 U/L; ALT: 85 U/L; ALP: 445 U/L: Test Date 29-May-2019 | $150.00 | ||||||||||||
| BBS0005-CF900037610052919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 50 Y | M | White | <-70C | 30-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | |||||||||||||
| BBS0005-CC900041238060419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 59 Y | F | White | <-70C | 05-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 196 U/L; ALT: 52 U/L; ALP: 830 U/L: Test Date 4-Jun-2019 | $150.00 | ||||||||||||
| BBS0005-CF900041239060219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 63 Y | F | Hispanic | <-70C | 03-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | |||||||||||||
| BBS0005-CF900041240052719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 25 Y | M | White | <-70C | 28-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 45 U/L; ALT: 70 U/L: Test Date 28-May-2019 | $150.00 | ||||||||||||
| BBS0005-CF900041241052719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 42 Y | F | Hispanic | <-70C | 28-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 395 U/L; ALT: 182 U/L: Test Date 28-May-2019 | $150.00 | ||||||||||||
| BBS0005-CF900041242060219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 48 Y | M | Hispanic | <-70C | 03-Jun-19 | Subject Risk Information | Long term hemodialysis patients; HIV infected individuals | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 286 U/L: Test Date 3-Jun-2019 | $150.00 | ||||||||||||
| BBS0005-CF900041243060219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 67 Y | M | Hawaiian | <-70C | 03-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | |||||||||||||
| BBS0005-CC900041244061119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 5.00 | $150.00 | 64 Y | M | White | <-70C | 12-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Dark colored urine; Jaundice; Right upper side abdominal pain; Elevated liver enzymes | AST: 65 U/L; ALT: 155 U/L; ALP: 140 U/L:Test Date 11-Jun-2019 | $150.00 | ||||||||||||
| BBS0005-CF900041245052819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 45 Y | F | White | <-70C | 29-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Dark colored urine; Elevated liver enzymes | AST: 381 U/L; ALT: 326 U/L; ALP: 422 U/L: Test Date 29-May-2019 | $150.00 | ||||||||||||
| BBS0005-CC900041246061019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 6.00 | $150.00 | 56 Y | M | Hispanic | <-70C | 11-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | |||||||||||||
| BBS0005-CF900045241052919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 60 Y | M | Hispanic | <-70C | 30-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | |||||||||||||
| BBS0005-CF900046339052919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 82 Y | F | White | <-70C | 30-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 58 U/L; ALP: 404 U/L: Test Date 30-May-2019 | $150.00 | ||||||||||||
| BBS0005-CC900046340060919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 3.00 | $150.00 | 59 Y | F | Hispanic | <-70C | 10-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice; Right upper side abdominal pain; Elevated liver enzymes | AST: 93 U/L; ALT: 187 U/L; ALP: 247 U/L: Test Date 8-Jun-2019 | $150.00 | ||||||||||||
| BBS0005-CF900046341062519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 26 Y | F | Black | <-70C | 26-Jun-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | |||||||||||||
| BBS0005-CF900046342072819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 33 Y | M | Hispanic | <-70C | 29-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 305 U/L | 29-Jul-2019 | $150.00 | ||||||||||||
| BBS0005-CF900046343062619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 66 Y | M | White | <-70C | 27-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 47 U/L; ALT: 61 U/L | 27-Jun-19 | $150.00 | ||||||||||||
| BBS0005-CF900046344072819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 80 Y | M | Black | <-70C | 29-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 279 U/L; ALT: 149 U/L; ALP: 248 U/L | 09-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900046345070219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 56 Y | F | Hispanic | <-70C | 03-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 43 U/L | 02-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900055629070919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 5.00 | $150.00 | 72 Y | M | White | <-70C | 10-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 49 U/L; ALT: 50 U/L | 09-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900055630070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 59 Y | F | Black | <-70C | 02-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 37 U/L | 01-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900055631071619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 60 Y | F | White | <-70C | 17-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Enlarged liver; Elevated liver enzymes | ALP: 144 U/L | 17-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900055632073019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 39 Y | F | Black | <-70C | 31-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 299 U/L | 31-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900055633072219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 42 Y | M | White | <-70C | 23-Jul-19 | Subject Risk Information | Current or former user of IV drugs | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-CF900055634070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 58 Y | F | Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 35 U/L; ALT: 63 | 02-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900055635072319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 63 Y | F | Black | <-70C | 24-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 344 U/L | 24-Jul-2019 | $150.00 | ||||||||||||
| BBS0005-CF900055636073019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 64 Y | M | Hispanic | <-70C | 31-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice; Elevated liver enzymes | AST: 37 U/L; ALT: 69 U/L; ALP: 285 U/L | 31-Jul-2019 | $150.00 | ||||||||||||
| BBS0005-CF900060369070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.25 | 2.00 | $150.00 | 51 Y | F | Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | |||||||||||||
| BBS0005-CF900060370072219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 79 Y | F | White | <-70C | 23-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-CF900060371072819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 78 Y | F | White | <-70C | 29-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 32 U/L | 29-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900060372070819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 67 Y | M | Asian | <-70C | 09-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 54 U/L; ALT: 65 U/L; ALP: 400 U/L | 8-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900060373063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 48 Y | F | American Indian | <-70C | 01-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 134 U/L | 30-Jun-19 | $150.00 | ||||||||||||
| BBS0005-CF900060374072119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 43 Y | F | Black | <-70C | 22-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 69 U/L; ALT: 72 U/L; ALP: 221 U/L | 22-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900060375062619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 18 Y | M | Hispanic | <-70C | 27-Jun-19 | Subject Risk Information | U/A | Suspect HCV:Pediatric | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 381 U/L | 26-Jun-19 | $150.00 | ||||||||||||
| BBS0005-CF900060376063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 79 Y | F | White | <-70C | 01-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 68 U/L; ALT: 71 U/L; ALP: 734 U/L | 30-Jun-19 | $150.00 | ||||||||||||
| BBS0005-CC900069835061019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 61 Y | F | White | <-70C | 11-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | |||||||||||||
| BBS0005-CF900069836072919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 24 Y | M | Hispanic | <-70C | 30-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 36 U/L; ALT: 61 U/L | 30-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900069837062619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 50 Y | M | Hispanic | <-70C | 27-Jun-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 113 U/L; ALT: 93 | 27-Jun-19 | $150.00 | ||||||||||||
| BBS0005-CF900069838073019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 54 Y | F | White | <-70C | 31-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 33 U/L; ALP: 529 U/L | 31-Jul-2019 | $150.00 | ||||||||||||
| BBS0005-CF900069839070919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 76 Y | F | Black | <-70C | 10-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 51 U/L | 09-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900069840072819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 17.00 | $150.00 | 59 Y | M | White | <-70C | 29-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-CF900069841071019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 54 Y | M | Black | <-70C | 11-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 45 U/L | 11-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900069842071719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 4.00 | $150.00 | 25 Y | F | White | <-70C | 18-Jul-19 | Subject Risk Information | Current or former user of IV drugs | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 41 U/L; ALT: 53 U/L; ALP: 182 U/L | 18-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900073335071719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 49 Y | M | Hispanic | <-70C | 18-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice; Elevated liver enzymes | AST: 52 U/L; ALT: 61 U/L; ALP: 309 U/L | 18-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900073336070719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 66 Y | M | White | <-70C | 08-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 70 U/L; ALT: 59 | 08-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900073337071619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 77 Y | F | Black | <-70C | 17-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 82 U/L; ALT: 122 U/L; ALP: 183 U/L | 17-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900073338070919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 69 Y | M | Black | <-70C | 10-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 37 U/L; ALT: 49 | 09-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900073339072119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 36 Y | M | Black | <-70C | 22-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 51 U/L; ALP: 151 U/L | 21-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900073340073019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 28 Y | F | Hispanic | <-70C | 31-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 55 U/L; ALT: 69 U/L | 31-Jul-19 | $150.00 | ||||||||||||
| BBS0000-A0900110139090219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 67 Y | M | Hispanic | <-70C | 03-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 75 U/L; ALP: 521 | $150.00 | No | No | No | No | ||||||||||
| BBS0005-CF900073341072219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 38 Y | M | Hispanic | <-70C | 23-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 133 U/L | 23-Jul-2019 | $150.00 | ||||||||||||
| BBS0005-CF900023452071019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 33 Y | F | White | <-70C | 11-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 133 U/L | 10-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900023453090919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 4.00 | $150.00 | 23 Y | F | Hispanic | <-70C | 10-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | ||||||||||||||
| BBS0005-CF900023454090419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 56 Y | F | Black | <-70C | 05-Sep-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992; Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | AST: 42 U/L | ALT: 83 U/L | 4-Sep-2019 | $150.00 | |||||||||||||
| BBS0005-CF900023455072219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 37 Y | M | Hispanic | <-70C | 23-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 37 U/L; ALT: 59 | 23-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900023456100819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 24 Y | F | Hispanic | <-70C | 09-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 95 U/L | ALT: 66 U/L | 8-Oct-19 | $150.00 | |||||||||||||
| BBS0005-CF900023457093019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 34 Y | F | Hispanic | <-70C | 01-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 61 U/L | 30-Sep-19 | $150.00 | |||||||||||||
| BBS0005-CF900023458101419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 70 Y | F | White | <-70C | 15-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-CF900023459100119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 72 Y | M | White | <-70C | 02-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes AST: 184 U/L; ALT: 126 U/L | 1-Oct-19 | $150.00 | |||||||||||||
| BBS0000-A0900107229082819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 34 Y | F | Black | <-70C | 29-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | Yes U/A | Yes U/A | No | No | ||||||||||
| BBS0000-CF900107230091119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 65 Y | F | Asian | <-70C | 12-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 31 U/L | 12-Sep-19 | $150.00 | Yes U/A | Yes U/A | No | Yes | |||||||||
| BBS0000-CF900107231090919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 66 Y | F | White | <-70C | 10-Sep-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 (1981) | Primary Signs and Symptoms | Elevated liver enzymes | AST: 57 U/L | 9-Sep-19 | $150.00 | No | No | No | Yes | |||||||||
| BBS0000-A0900107232082619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 44 Y | M | Hispanic | <-70C | 27-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Jaundice; Right upper side abdominal pain; Elevated liver enzymes | AST: 164 U/L | ALT: 141 U/L | ALP: 626 U/L | $150.00 | No | No | No | No | ||||||||||
| BBS0000-CF900107233093019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 36 Y | M | Hispanic | <-70C | 01-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | ASP: 505 U/L | 30-Sep-19 | $150.00 | U/A | U/A | No | Yes | |||||||||
| BBS0000-A0900107234090919DD | Suspect Hepatitis C (HCV) | USA | Serum | 7.00 | $150.00 | 47 Y | F | Hispanic | <-70C | 10-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Ascites, Elevated liver enzymes | ALP: 257 U/L | 9-Sep-19 | $150.00 | No | No | No | Yes | ||||||||||
| BBS0005-CF900026482100119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 72 Y | M | White | <-70C | 02-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-A0900107235090219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 46 Y | M | Hispanic | <-70C | 03-Sep-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-CF900099078091119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 21 Y | M | Hispanic | <-70C | 12-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Dark colored urine, Elevated liver enzymes | AST: 685 U/L | ALT: 235 U/L | 12-Sep-19 | $150.00 | |||||||||||||
| BBS0000-CF900099079092419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 57 Y | F | Black | <-70C | 25-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-CF900099080091819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 74 Y | M | White | <-70C | 19-Sep-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 | Primary Signs and Symptoms | Ascites, Elevated liver enzymes | AST: 60 U/L | ALP: 162 U/L | 17-Sep-19 | $150.00 | |||||||||||||
| BBS0000-CF900099081090419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 26 Y | M | White | <-70C | 05-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 43 U/L | ALT: 107 | 4-Sep-19 | $150.00 | |||||||||||||
| BBS0000-CF900099082091119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 66 Y | M | White | <-70C | 12-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-CF900099083092419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 72 Y | F | Hispanic | <-70C | 25-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-A0900109655082619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 60 Y | M | White | <-70C | 27-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 38 U/L | ALP: 299 U/L | $150.00 | No | No | No | No | ||||||||||
| BBS0000-CF900099084091119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 44 Y | F | Hispanic | <-70C | 12-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 50 U/L | 12-Sep-19 | $150.00 | |||||||||||||
| BBS0000-CF900099948093019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 5.00 | $150.00 | 37 Y | F | White | <-70C | 01-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-CF900099949101619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 63 Y | M | White | <-70C | 17-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-CF900099950100619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 4.00 | $150.00 | 62 Y | M | Hispanic | <-70C | 07-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 39 U/L | ALP: 253 U/L | 7-Oct-2019 | $150.00 | |||||||||||||
| BBS0000-A0900111860082619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 55 Y | F | White | <-70C | 27-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | No | No | No | No | ||||||||||
| BBS0000-CF900099951100819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 51 Y | M | Hispanic | <-70C | 09-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 165 U/L | 9-Oct-2019 | $150.00 | |||||||||||||
| BBS0000-CF900099952091119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 5.00 | $150.00 | 43 Y | F | Hispanic | <-70C | 12-Sep-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992; Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-CF900099953091819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 17.00 | $150.00 | 67 Y | F | Black | <-70C | 19-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-CF900099954091819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 27 Y | F | Hispanic | <-70C | 19-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 86 U/L | ALT: 79 U/L | 19-Sep-19 | $150.00 | |||||||||||||
| BBS0000-A0900109888090319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 54 Y | F | Black | <-70C | 04-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965; Former user of IV drugs | Primary Signs and Symptoms | N/A | $150.00 | No | Yes 19-Aug-19 | No | No | ||||||||||
| BBS0000-CF900100813092419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 6.00 | $150.00 | 57 Y | M | White | <-70C | 25-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-A0900109889082819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 46 Y | M | American Indian | <-70C | 29-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 96 U/L | ALP: 166 U/L | $150.00 | Unknown | U/A | Yes | Unknown | ||||||||||
| BBS0000-A0900109890090419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 2.00 | $150.00 | 59 Y | F | Black | <-70C | 05-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 135 U/L | $150.00 | Yes U/A | Yes U/A | No | No | ||||||||||
| BBS0000-CF900100814091119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 65 Y | F | Hispanic | <-70C | 12-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-A0900109891082819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 5.00 | $150.00 | 57 Y | M | Hispanic | <-70C | 29-Aug-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 181 U/L | ALT: 83 U/L | $150.00 | Yes U/A | U/A | No | Yes | ||||||||||
| BBS0000-CF900100815092319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 65 Y | M | White | <-70C | 24-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-CF900100816092519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 34 Y | F | White | <-70C | 26-Sep-19 | Subject Risk Information | Current or former user of IV drugs (former) | Primary Signs and Symptoms | Elevated liver enzymes | AST: 139 U/L | ALT: 194 U/L | ALP: 235 U/L | 25-Sep-19 | $150.00 | |||||||||||||
| BBS0005-CF900022539070919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 21 Y | F | Hispanic | <-70C | 10-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 61 U/L; ALT: 73 | 09-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900022540052819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 54 Y | F | Hispanic | <-70C | 29-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | |||||||||||||
| BBS0005-CF900022541072119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 59 Y | M | Hispanic | <-70C | 22-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 51 U/L; ALP: 216 U/L | 21-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CC900022542060319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 17.00 | $150.00 | 27 Y | M | Black | <-70C | 04-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 80 U/L; ALT: 108 U/L; ALP: 802 U/L: Test Date 4-Jun-2019 | $150.00 | ||||||||||||
| BBS0005-CF900022543072119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 17.00 | $150.00 | 25 Y | F | Black | <-70C | 22-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 89 U/L | 21-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900022544071719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 70 Y | F | White | <-70C | 18-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 34 U/L; ALP: 245 U/L | 18-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900022545070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 66 Y | M | Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-CF900022546070819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 76 Y | F | Asian | <-70C | 09-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 64 U/L; ALT: 61 U/L | 09-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CF900024130071019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 43 Y | M | Hispanic | <-70C | 11-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 40 U/L; ALT: 58 U/L | 10-Jul-19 | $150.00 | ||||||||||||
| BBS0005-CC900024131061119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 84 Y | F | Black | <-70C | 12-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 33 U/L: Test Date 11-Jun-2019 | $150.00 | ||||||||||||
| BBS0005-CF900024132072819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 29 Y | F | Hispanic | <-70C | 29-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 42 U/L | 29-Jul-2019 | $150.00 | ||||||||||||
| BBS0005-CF900024133100719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 58 Y | F | Hispanic | <-70C | 08-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-CF900024134091719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 55 Y | M | Hispanic | <-70C | 18-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-CF900024135101419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 3.00 | $150.00 | 68 Y | M | Hispanic | <-70C | 15-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 60 U/L | ALT: 65 U/ | ALP: 150 U/L | 14-Oct-19 | $150.00 | |||||||||||||
| BBS0000-A0900111829090219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 43 Y | M | White | <-70C | 03-Sep-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | Yes U/A | Yes U/A | No | No | ||||||||||
| BBS0005-CF900024136100619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 67 Y | M | Asian | <-70C | 07-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-CF900041397101419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 71 Y | F | Asian | <-70C | 15-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-CF900041398100619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 56 Y | M | White | <-70C | 07-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 327 U/L | 7-Oct-19 | $150.00 | |||||||||||||
| BBS0005-CF900041399101419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 65 Y | F | White | <-70C | 15-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-A0900111739082019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 31 Y | F | Hispanic | <-70C | 21-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | Yes U/A | Yes 30-Jul-98 | No | No | ||||||||||
| BBS0000-CF900107592101419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 68 Y | M | White | <-70C | 15-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 225 U/L | 14-Oct-19 | $150.00 | No | No | No | No | |||||||||
| BBS0005-CF900046508092319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 36 Y | M | Black | <-70C | 24-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 65 U/L | | 24-Sep-19 | $150.00 | |||||||||||||
| BBS0005-CF900046509101419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 59 Y | M | White | <-70C | 15-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 77 U/L; ALP: 138 U/L | 15-Oct-19 | $150.00 | |||||||||||||
| BBS0000-A0900111740082519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 43 Y | F | Hispanic | <-70C | 26-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 58 U/L | ALT: 98 U/L | $150.00 | U/A U/A | U/A | No | No | ||||||||||
| BBS0005-CF900046510101619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 64 Y | M | White | <-70C | 17-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-CF900046511091719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 53 Y | F | Hispanic | <-70C | 18-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 47 U/L | ALT: 42 U/L | 17-Sep-19 | $150.00 | |||||||||||||
| BBS0005-CF900046512091719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 57 Y | F | Hispanic | <-70C | 18-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 157 U/L | 17-Sep-19 | $150.00 | |||||||||||||
| BBS0005-CF900046513100719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 6.00 | $150.00 | 74 Y | F | White | <-70C | 08-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-CF900046514092419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 51 Y | F | Black | <-70C | 25-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 36 U/L | ALT: 40 U/L | 25-Sep-19 | $150.00 | |||||||||||||
| BBS0005-CF900057233091619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 56 Y | M | White | <-70C | 17-Sep-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 (1986); Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-CF900057234093019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 59 Y | F | White | <-70C | 01-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-A0900111721081419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 82 Y | M | White | <-70C | 15-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 69 U/L | ALT: 119 U/L | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900111722082519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 20 Y | F | Hispanic | <-70C | 26-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain | Elevated liver enzymes AST: 126 U/L | ALT: 192 U/L | ALP: 304 U/L | $150.00 | Yes U/A | Yes U/A | No | No | ||||||||||
| BBS0005-CF900057235100919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 56 Y | F | White | <-70C | 10-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Ascites | $150.00 | ||||||||||||||
| BBS0005-CF900057236101519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 6.00 | $150.00 | 47 Y | M | Hispanic | <-70C | 16-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | ||||||||||||||
| BBS0005-CF900057237102019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 73 Y | M | White | <-70C | 21-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 240 U/L; ALT: 133 U/L | ALP: 532 U/L | 20-Oct-19 | $150.00 | |||||||||||||
| BBS0005-CF900057238092519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 69 Y | F | Asian | <-70C | 26-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-CF900057241092519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 56 Y | M | White | <-70C | 26-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-A0900110159082619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 38 Y | M | Hispanic | <-70C | 27-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 47 U/L | $150.00 | No | No | No | No | ||||||||||
| BBS0005-CF900062531101519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 71 Y | M | Hispanic | <-70C | 16-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | ||||||||||||||
| BBS0000-A0900110160082019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 44 Y | M | White | <-70C | 21-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes AST: 55 U/L | ALT: 60 U/L | ALP: 174 U/L | $150.00 | U/A | Yes 31-Oct-92 | No | No | ||||||||||
| BBS0000-A0900110161081319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 71 Y | M | Hispanic | <-70C | 14-Aug-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 174 U/L | ALT: 80 U/L | $150.00 | U/A | U/A | No | No | ||||||||||
| BBS0005-CF900062532101619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 59 Y | F | American Indian | <-70C | 17-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 45 U/L | 16-Oct-19 | $150.00 | |||||||||||||
| BBS0000-A0900110162081419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 53 Y | F | Hispanic | <-70C | 15-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 191 U/L | $150.00 | Yes U/A | Yes U/A | No | No | ||||||||||
| BBS0005-CF900062533102019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 67 Y | M | White | <-70C | 21-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-CF900062534100619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 68 Y | M | White | <-70C | 07-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-CF900069990090419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 19.00 | $150.00 | 71 Y | F | Hispanic | <-70C | 05-Sep-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992; Adult born from 1945 through 1965; Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | AST: 73 U/L | ALT: 40 U/L | ALP: 408 U/L | 5-Sep-19 | $150.00 | |||||||||||||
| BBS0000-A0900110140081319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 24 Y | F | Hispanic | <-70C | 14-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain | Elevated liver enzymes | AST: 34 U/L | $150.00 | Yes U/A | Yes U/A | No | No | ||||||||||
| BBS0005-CF900069991091819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 5.00 | $150.00 | 61 Y | F | White | <-70C | 19-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 45 U/L | 19-Sep-19 | $150.00 | |||||||||||||
| BBS0005-CF900069992102019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 19.00 | $150.00 | 26 Y | M | Hispanic | <-70C | 21-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 61 U/L | ALT: 78 U/L | 20-Oct-19 | $150.00 | |||||||||||||
| BBS0005-CF900069993091619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 55 Y | F | White | <-70C | 17-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 32 U/L | 16-Sep-19 | $150.00 | |||||||||||||
| BBS0005-CF900069994100119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 68 Y | F | Hispanic | <-70C | 02-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-CF900069995100919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 18.00 | $150.00 | 49 Y | M | Hispanic | <-70C | 10-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Ascites; Enlarged liver; Elevated liver enzymes | AST: 59 U/L | ALT: 62 U/L | ALP: 151 U/L | 9-Oct-19 | $150.00 | |||||||||||||
| BBS0000-A0900110141082119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 56 Y | M | American Indian | <-70C | 22-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 115 U/L | ALT: 179 U/L | ALP: 142 U/L | $150.00 | Yes U/A | Yes 17-Jul-17 | No | No | ||||||||||
| BBS0000-A0900110142081819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 1.00 | $150.00 | 51 Y | F | Hispanic | <-70C | 19-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 167 U/L | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900110143081919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 76 Y | F | American Indian | <-70C | 20-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 35 U/L | ALP: 201 U/L | $150.00 | No | No | No | No | ||||||||||
| BBS0005-CF900073887102019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 64 Y | M | White | <-70C | 21-Oct-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0005-CF900073888081219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 3.00 | $150.00 | 75 Y | M | Black | <-70C | 13-Aug-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 48 U/L | 12-Aug-19 | $150.00 | ||||||||||||
| BBS0005-CF900073889081219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 28 Y | M | Black | <-70C | 13-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0000-A0900110144082019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 18.00 | $150.00 | 74 Y | F | White | <-70C | 21-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 56 U/L | ALT: 60 U/L | $150.00 | Yes 17-Mar-2000 | 24-Sep-1999 | Yes 17-Jul-63 | No | No | ||||||||||
| BBS0000-A0900110145081819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 60 Y | M | White | <-70C | 19-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 39 U/L | ALT: 52 U/L | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900107317070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 72 Y | M | White | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 19-Feb-2019 | No | Yes | |||||||||
| BBS0000-A0900107318070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 67 Y | M | White | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | Yes Date of Vaccination: 16-Oct-2018 | No | No | |||||||||
| BBS0000-A0900107319070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 68 Y | M | White | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||
| BBS0000-A0900107320070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 65 Y | F | White | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||
| BBS0000-A0900107321063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 62 Y | M | White | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 2/19/2018 | No | No | |||||||||
| BBS0000-A0900107304070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 59 Y | M | White | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 5/18/2019 | No | No | |||||||||
| BBS0000-A0900107219063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 57 Y | M | Black | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 10/12/2016 | No | No | |||||||||
| BBS0000-A0900107220070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 39 Y | F | White | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | Yes Date of Vaccination: 4/12/2012 | No | No | |||||||||
| BBS0000-A0900107221070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 63 Y | F | White | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | Yes Date of Vaccination: 6/16/2016 | No | No | |||||||||
| BBS0000-A0900107222063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 61 Y | M | Black | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 11/18/2017 | No | No | |||||||||
| BBS0000-A0900107210070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 69 Y | M | Black | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 3/19/2019 | No | No | |||||||||
| BBS0000-A0900107211063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 61 Y | M | Black | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 2/14/2007 | No | No | |||||||||
| BBS0000-A0900109699070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 69 Y | F | Black | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 11/18/2017 | No | No | |||||||||
| BBS0000-A0900109700070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 72 Y | M | White | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 1/16/2018 | No | No | |||||||||
| BBS0000-A0900109701070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 64 Y | M | White | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 24-Nov-18 | No | No | |||||||||
| BBS0000-A0900109702070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 62 Y | F | White | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 4/16/2019 | No | No | |||||||||
| BBS0000-A0900109703063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 92 Y | F | White | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 10/21/2016 | No | No | |||||||||
| BBS0000-A0900109704070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 72 Y | F | White | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 8/19/2017 | No | Yes | |||||||||
| BBS0000-A0900109816063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 55 Y | F | White | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 6/17/2019 | No | No | |||||||||
| BBS0000-A0900109817070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 68 Y | M | White | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 2/19/2019 | No | No | |||||||||
| BBS0000-A0900109818063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 60 Y | F | White | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 7/14/2017 | No | No | |||||||||
| BBS0000-A0900109819063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 59 Y | M | White | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 5/20/2019 | No | No | |||||||||
| BBS0000-A0900109820063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 38 Y | F | Black | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | U/A | No | No | |||||||||
| BBS0000-A0900109821070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 62 Y | M | White | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | Yes Date of Vaccination: 9/15/2016 | No | No | |||||||||
| BBS0000-A0900109909063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 52 Y | F | Italian | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | Yes Date of Vaccination: 5/20/2019 | No | Yes | |||||||||
| BBS0000-A0900109910063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 52 Y | M | White | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | U/A | No | No | No | |||||||||
| BBS0000-A0900109920070219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 59 Y | M | Black | <-70C | 03-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||
| BBS0000-A0900109921080619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 58 Y | M | Black | <-70C | 07-Aug-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992, Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900109922100319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 63 Y | Female | White | <-70C | 04-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900108389072819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 75 Y | M | White | <-70C | 29-Jul-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||
| BBS0000-A0900110018063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 48 Y | M | Black | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||
| BBS0000-A0900110019072819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 71 Y | F | Black | <-70C | 29-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Dark colored urine | $150.00 | No | No | No | No | |||||||||
| BBS0000-A0900110020063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 58 Y | M | Black | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||
| BBS0000-A0900110021070719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 36 Y | M | Black | <-70C | 08-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Dark colored urine | $150.00 | No | No | No | No | |||||||||
| BBS0000-A0900110022072819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 42 Y | M | Black | <-70C | 29-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900108389101019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 42 Y | U/A | White | <-70C | 11-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $150.00 | No | yes 11-Oct-19 | No | No | ||||||||||
| BBS0000-A0900110018092919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 49 Y | Male | White | <-70C | 30-Sep-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900107835063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 63 Y | F | Black | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||
| BBS0000-A0900111774080419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 6.00 | $150.00 | 63 Y | M | Black | <-70C | 05-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900111775072819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 54 Y | F | Black | <-70C | 29-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||
| BBS0000-A0900111776063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 61 Y | F | Black | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||
| BBS0000-A0900111777080419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 73 Y | F | Black | <-70C | 05-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900111778072819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 50 Y | F | Black | <-70C | 29-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900111779070719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 34 Y | F | Black | <-70C | 08-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||
| BBS0000-A0900111759080619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 70 Y | F | Black | <-70C | 07-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900111760080619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 77 Y | F | Black | <-70C | 07-Aug-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900111761070719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 31 Y | F | Black | <-70C | 08-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||
| BBS0000-A0900110019092419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 61 Y | Female | Black | <-70C | 25-Sep-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900110020090519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 67 Y | Female | Black | <-70C | 06-Sep-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900111762070819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 3.00 | $150.00 | 45 Y | F | Black | <-70C | 09-Jul-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||
| BBS0000-A0900111763082719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 66 Y | M | Black | <-70C | 28-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900110021090519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 55 Y | Male | Black | <-70C | 06-Sep-19 | Subject Risk Information | Current or former user of IV drugs; Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900110196063019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 63 Y | F | Black | <-70C | 01-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||
| BBS0000-A0900110022091619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 46 Y | Male | Black | <-70C | 17-Sep-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900110197092919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 59 Y | Female | Black | <-70C | 30-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900110198080419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | Y | M | Black | <-70C | 05-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | No | No | Yes | No | ||||||||||
| BBS0000-A0900110199070819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 51 Y | M | Black | <-70C | 09-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||
| BBS0000-A0900110200082819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 34 Y | F | Black | <-70C | 29-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900111741082819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 37 Y | M | White | <-70C | 29-Aug-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992, Long term hemodialysis patient | Primary Signs and Symptoms | Dark colored urine | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900111742070719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 68 Y | F | Black | <-70C | 08-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||
| BBS0000-A0900111743082719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 72 Y | M | Black | <-70C | 28-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 ,Recipient of clotting factor concentrates produced before 1987; Healthcare, emergency medical and public health workers after needle stick, sharps or mucosal exposure to HCV positive blood | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900111744091619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 33 Y | Male | Black | <-70C | 17-Sep-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900111745082719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 66 Y | F | Black | <-70C | 28-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-CC900022690093019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 58 Y | Male | Black | <-70C | 01-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-CC900024277100319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 82 Y | Male | White | <-70C | 04-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-CC900024278090919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 54 Y | Male | Black | <-70C | 10-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-A0900111723070219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 54 Y | F | Black | <-70C | 03-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||
| BBS0000-CC900024279090919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 56 Y | Male | Black | <-70C | 10-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-CC900024282092419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 60 Y | Male | Black | <-70C | 25-Sep-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-A0900111724070719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 38 Y | F | Black | <-70C | 08-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||
| BBS0000-CC900024283091619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 56 Y | Female | Black | <-70C | 17-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-A0900111725080619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 63 Y | M | Black | <-70C | 07-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900110163082719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 47 Y | M | White | <-70C | 28-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900110164080419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 69 Y | F | Black | <-70C | 05-Aug-19 | Subject Risk Information | Recipient of clotting factor concentrates produced before 1987; Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-CC900024284092319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 56 Y | Female | Black | <-70C | 24-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | ||||||||||||||
| BBS0000-A0900111716082719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 60 Y | F | Black | <-70C | 28-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| NBP0200-CC900024285092519DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 10.00 | $150.00 | 66 Y | Male | Black | <-70C | 26-Sep-19 | Subject Risk Information | Recipient of clotting factor concentrates produced before 1987; Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | |||||||||||
| BBS0000-A0900111704070419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $90.00 | 39 Y | M | Black | <-70C | 05-Jul-19 | Subject Risk Information | Recipient of clotting factor concentrates produced before 1987; Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $90.00 | No | No | No | No | |||||||||
| BBS0000-CC900024286090519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 67 Y | Male | Pacific Islander | <-70C | 06-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-A0900110146080419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 77 Y | M | White | <-70C | 05-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | No | No | No | No | ||||||||||
| BBS0000-MB900105625070819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 57 Y | M | Black | <-70C | 09-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Yes U/A | Yes U/A | |||||||||||
| BBS0000-MB900105626070819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 54 Y | F | Black | <-70C | 09-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Yes U/A | Yes U/A | |||||||||||
| BBS0005-MB900057910070819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 23 Y | F | Black | <-70C | 09-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900057911070919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 63 Y | F | White | <-70C | 10-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900057912070919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 56 Y | M | Black | <-70C | 10-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900057913070919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 26 Y | M | Black | <-70C | 10-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900057914070919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 50 Y | F | Black | <-70C | 10-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900057915070919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 42 Y | M | White | <-70C | 10-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 48 U/L | $150.00 | |||||||||||||
| BBS0005-MB900057916071419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 40 Y | F | Black | <-70C | 15-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900064428071419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 39 Y | F | Black | <-70C | 15-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900064429071419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 59 Y | M | Black | <-70C | 15-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900064430071519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 20 Y | F | Black | <-70C | 16-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900064431071619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 60 Y | M | Black | <-70C | 17-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900064432071719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 62 Y | F | Black | <-70C | 18-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900064433071719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 18.00 | $150.00 | 68 Y | M | Black | <-70C | 18-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900064434071719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 44 Y | F | White | <-70C | 18-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900064435071719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 51 Y | M | Black | <-70C | 18-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900064436071719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 55 Y | M | Black | <-70C | 18-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900064437071719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 56 Y | F | Black | <-70C | 18-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 37 U/L; ALP: 235 U/L | $150.00 | |||||||||||||
| BBS0005-MB900031803072219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 53 Y | M | Black | <-70C | 23-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ASLT: 42 U/L | $150.00 | |||||||||||||
| BBS0005-MB900031804072319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 54 Y | M | Black | <-70C | 24-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900031805072319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 56 Y | F | White | <-70C | 24-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900034882072319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 54 Y | F | Black | <-70C | 24-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900034883072419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 62 Y | F | Black | <-70C | 25-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900034884072419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 57 Y | M | Black | <-70C | 25-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900034885072419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 69 Y | F | White | <-70C | 25-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 46 U/L; ALT: 39 U/L | $150.00 | |||||||||||||
| BBS0005-MB900034886072419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 49 Y | M | White | <-70C | 25-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900034887073019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 52 Y | F | Black | <-70C | 31-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900034888073019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 29 Y | M | White | <-70C | 31-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900038353073119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 63 Y | M | Black | <-70C | 01-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900038354080419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 50 Y | M | Black | <-70C | 05-Aug-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900038355080519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 50 Y | F | Black | <-70C | 06-Aug-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900038356080719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 56 Y | F | Black | <-70C | 08-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900038357080719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 23 Y | F | Black | <-70C | 08-Aug-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900038363081219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 54 Y | M | Black | <-70C | 13-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965; Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900038364081219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 17.00 | $150.00 | 62 Y | M | Black | <-70C | 13-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900038365081219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 47 Y | M | Black | <-70C | 13-Aug-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900038366081219DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 21 Y | M | Black | <-70C | 13-Aug-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900038367081419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 46 Y | M | Black | <-70C | 15-Aug-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900046698081819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 56 Y | M | Black | <-70C | 19-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900046699081819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 24 Y | F | Black | <-70C | 19-Aug-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900046708081919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 47 Y | F | Black | <-70C | 20-Aug-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900046709081919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 57 Y | M | Black | <-70C | 20-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900046710082019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 60 Y | M | Black | <-70C | 21-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | |||||||||||||
| BBS0005-MB900046711082019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 62 Y | M | Black | <-70C | 21-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 |
Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.
Please read carefully before purchasing:
Clinical specimens for research use only.
Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.
If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341
These products are supplied without warranty for suitability for specific applications or analytical determinations.
Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.